A neurological bridge between hearing loss and cognitive decline

Age-related hearing loss affects roughly one-third of people over 65 and nearly half of those over 75. Its consequences extend beyond the auditory system. Epidemiological studies have linked hearing loss to elevated rates of cognitive decline and dementia, but the biological pathway connecting damaged ears to deteriorating cognition has been difficult to trace precisely.

A study published in eNeuro, the open-access journal of the Society for Neuroscience, now offers a specific neurobiological candidate. Researchers at Tiangong University and Shandong Provincial Hospital, led by Ning Li, identified a measure called the Functional-Structural Ratio (FSR) that may serve as a link between hearing loss and cognitive decline in people with presbycusis - the most common form of age-related hearing impairment.

What the FSR measures and why it matters

The Functional-Structural Ratio captures the relationship between functional brain connectivity - how actively brain regions communicate with each other during activity - and structural integrity - the physical health of the brain tissue itself. A declining FSR in a given brain region suggests that both its structural health and its functional integration with other regions are deteriorating simultaneously.

The researchers found that four specific brain regions showed reduced FSR in participants with presbycusis compared to normal-hearing controls. Two of these - the putamen and the fusiform gyrus - are involved in processing sound and speech. The other two - the precuneus and medial superior frontal gyrus - are involved in memory and executive decision-making. Reduced connectivity in all four regions correlated with worse hearing thresholds and poorer performance on memory and executive function tests.

This dual involvement is what makes the FSR potentially significant: hearing loss is not merely reducing input to auditory processing centers, but appears to affect regions not primarily devoted to hearing, including areas central to memory and higher cognitive function.

A coordinated decline

"The most important takeaway is that preserving hearing health may protect brain integrity," said lead researcher Ning Li. "Because changes in the FSR correlate with both hearing loss and cognitive decline, this ratio could eventually serve as a biomarker - a tool for doctors to identify who is at the highest risk for dementia simply by looking at their brain scans."

The researchers interpret their findings as evidence that hearing loss involves a coordinated decline in both brain structure and function - not just degraded sensory processing in isolation. The auditory deprivation created by hearing loss may reduce stimulation to broad neural networks, accelerating structural and functional changes that contribute to cognitive decline.

Limitations to consider

The study is cross-sectional: it compared participants with presbycusis to those without at a single point in time. It cannot establish whether reduced FSR preceded cognitive decline, followed it, or developed in parallel. Longitudinal studies tracking the same individuals over years would be needed to determine the temporal relationship and assess whether hearing interventions - such as hearing aids or cochlear implants - can preserve FSR and cognitive function.

The sample was drawn from specific hospitals in China. Whether FSR differences generalize across diverse populations with different lifestyles, educational backgrounds, and health profiles is not yet known. The FSR measure itself is also not yet standardized for clinical use and would require validation across independent datasets before it could function as a practical screening tool.

Why this connects to dementia prevention

Hearing loss is considered a modifiable risk factor for dementia in current public health frameworks. The Lancet Commission on dementia prevention estimates that around 7% of dementia cases worldwide may be attributable to hearing loss in midlife. If the FSR proves to be a valid biomarker, it would provide clinicians with a brain-based measure to identify high-risk individuals earlier and potentially track whether interventions are having measurable neurological effects.